REGN

REGENERON PHARMACEUTICALS

REGN·75886F107·US·Common Stock·Healthcare - Biotechnology-13D/G

REGN (REGENERON PHARMACEUTICALS) is held by 328 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($6.9B), VANGUARD CAPITAL MANAGEMENT LLC ($5.1B), STATE STREET CORP ($3.6B). Net institutional sentiment: Mixed. In Q1 2026, 8 members of Congress and 188 funds bought REGN.

328
Holders
(28 Elite)
$62.8B
Total Value
56% (337)
Consensus
188 buying - 149 selling
13F: Insider & Congress:
REGNSmart Money Verdict
View all
Held by 328 funds
28 elite
Who's Trading
InsiderRFRYAN ARTHUR FSell $130KJul 2, 2026
CongressGilbert CisnerosGilbert CisnerosSale $1,001 - $15,000May 15, 2026
InsiderRFRYAN ARTHUR FSell $4KMay 1, 2026
InsiderRFRYAN ARTHUR FSell $11KMay 1, 2026
InsiderRFRYAN ARTHUR FSell $17KMay 1, 2026
ActivistVAVanguard Capital Management7.4%Apr 30, 2026
CongressRohit KhannaRohit KhannaBuy $1,001 - $15,000Apr 13, 2026
ActivistThe Vanguard GroupThe Vanguard Group0.0%Mar 27, 2026
CongressJulia LetlowJulia LetlowBuy $1,001 - $15,000Feb 12, 2026
CongressRohit KhannaRohit KhannaBuy $1,001 - $15,000Dec 4, 2025
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
8.9M(+2.4%)$6.9B0.1%-4.02%
39
New
6.7M$5.1B0.1%-13.32%
53
Increased
4.7M(+0.1%)$3.6B0.1%-23.82%
38
Decreased
4.5M(-3.0%)$3.4B1.9%+8.13%
0
Increased
4.3M(+9.4%)$3.2B0.2%-5.13%
42
Increased
2.7M(+6.3%)$2.1B0.5%-15.43%
48
Increased
2.6M(+3.5%)$2B0.1%+25.40%
40
Increased
2.2M(+11.7%)$1.7B0.2%-14.19%
43
Increased
2.1M(+2.7%)$1.6B0.4%-0.18%
39
Decreased
1.9M(-1.1%)$1.5B2.0%+43.49%
0
Increased
1.8M(+176.5%)$1.4B0.3%-13.52%
62
Increased
1.7M(+8.4%)$1.3B0.2%-2.53%
41
New
1.7M$1.3B0.1%-13.32%
44
Decreased
1.5M(-34.5%)$1.2B0.1%-6.56%
0
Increased
1.4M(+1.5%)$1.1B0.1%+73.38%
39
Decreased
1.3M(-5.0%)$1B0.1%-28.25%
0
Increased
1.3M(+18.5%)$1B0.1%-3.97%
45
Increased
1.2M(+23.6%)$946M0.4%+1.26%
46
Increased
1.2M(+2.8%)$919.1M0.1%-0.88%
33
Increased
1M(+27.5%)$780.2M0.2%-9.87%
47

Showing 1-20 of 341

1 / 18

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used